Immunogenic Mycobacterium africanum strains associated with ongoing transmission in The Gambia

Emerg Infect Dis. 2013 Oct;19(10):1598-1604. doi: 10.3201/eid1910.121023.

Abstract

In West Africa, Mycobacterium tuberculosis strains co-circulate with M. africanum, and both pathogens cause pulmonary tuberculosis in humans. Given recent findings that M. tuberculosis T-cell epitopes are hyperconserved, we hypothesized that more immunogenic strains have increased capacity to spread within the human host population. We investigated the relationship between the composition of the mycobacterial population in The Gambia, as measured by spoligotype analysis, and the immunogenicity of these strains as measured by purified protein derivative-induced interferon-γ release in ELISPOT assays of peripheral blood mononuclear cells. We found a positive correlation between strains with superior spreading capacity and their relative immunogenicity. Although our observation is true for M. tuberculosis and M. africanum strains, the association was especially pronounced in 1 M. africanum sublineage, characterized by spoligotype shared international type 181, which is responsible for 20% of all tuberculosis cases in the region and therefore poses a major public health threat in The Gambia.

Keywords: ELISPOT; Mycobacterium africanum; Mycobacterium tuberculosis; PPD; SIT; The Gambia; human hosts; immunogenicity; population structure; shared international type; spoligotyping; transmission; tuberculosis and other mycobacteria.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cluster Analysis
  • Gambia / epidemiology
  • Genotype
  • Humans
  • Interferon-gamma / blood
  • Molecular Typing
  • Mycobacterium / genetics
  • Mycobacterium / immunology*
  • Tuberculosis, Pulmonary / epidemiology
  • Tuberculosis, Pulmonary / immunology
  • Tuberculosis, Pulmonary / microbiology
  • Tuberculosis, Pulmonary / transmission*

Substances

  • Interferon-gamma